Progress, challenges and perspectives in the management of hypopituitarism

Cesar Luiz Boguszewski*, Sebastian Neggers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review


Hypopituitarism is a rare endocrine disorder characterized by insufficient hormone secretion from the pituitary gland. This condition leads to deficient production of one or more pituitary hormones, including growth hormone (GH), thyroid-stimulating hormone (TSH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), adrenocorticotropic hormone (ACTH), and antidiuretic hormone (ADH), also called arginine vasopressin (AVP). Symptoms vary widely and are often not, late recognized. Diagnosis typically involves a thorough clinical evaluation, hormone level assessments, and neuroimaging studies to identify underlying causes. Treatment aims to replace deficient hormones and address the underlying cause and related complications when possible. In this special issue we address diagnosis, comorbidities, and management of hypopituitarism. We hope that it will help healthcare professionals to manage their patients.

Original languageEnglish
Pages (from-to)453-455
Number of pages3
JournalReviews in Endocrine and Metabolic Disorders
Issue number3
Publication statusPublished - Jun 2024

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.


Dive into the research topics of 'Progress, challenges and perspectives in the management of hypopituitarism'. Together they form a unique fingerprint.

Cite this